India, Jan. 13 -- image credit- freepik
US-based Lantern Pharma Inc., a pioneer in AI-driven precision oncology and computational therapeutic development, has announced the establishment of an AI Centre of Excellence and Advanced Agentic Labs in Bengaluru.
This strategic initiative represents a critical inflection point in Lantern's evolution-transitioning from pioneering AI-enabled drug discovery in cancer to industrialising those capabilities at global scale for the broader drug development community.
As pharmaceutical companies increasingly shift from AI experimentation to enterprise-scale deployment, Lantern's Bengaluru centre will serve as the company's global scale-up center for the AI platform, providing expanded computational c...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.